Farther Finance Advisors’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$24.5K Buy
689
+606
+730% +$23.9K ﹤0.01% 3989
2026
Q2
$3.85K Buy
83
+42
+102% +$1.51K ﹤0.01% 4927
2026
Q1
$1K Buy
41
+15
+58% +$355 ﹤0.01% 5106
2025
Q4
$645 Sell
26
-39
-60% -$1.04K ﹤0.01% 5009
2025
Q3
$1.84K Buy
65
+46
+242% +$1.25K ﹤0.01% 4166
2025
Q2
$473 Buy
19
+17
+850% +$479 ﹤0.01% 4054
2025
Q1
$60 Sell
2
-1
-33% -$33 ﹤0.01% 4108
2024
Q4
$95 Sell
3
-1
-25% -$47 ﹤0.01% 3793
2024
Q3
$230 Buy
4
+3
+300% +$147 ﹤0.01% 3622
2024
Q2
$40 Hold
1
– – ﹤0.01% 3714
2024
Q1
$42 Hold
1
– – ﹤0.01% 3475
2023
Q4
$38 Buy
+1
New +$33 ﹤0.01% 3411

Other funds holding ASTH

Farther Finance Advisors's ASTH Position: Q3 2026 in Review

Farther Finance Advisors increased its Astrana Health (ASTH) stake by 730% in Q3 2026, buying an estimated $23.9K and bringing the position to 689 shares worth $24.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3989.

Farther Finance Advisors first reported a position in ASTH in Q4 2023 and has held it in 12 quarters since. 11 funds tracked by Wall St. Rank hold ASTH as of Q3 2026.

  • Farther Finance Advisors held 689 shares of Astrana Health worth $24.5K as of Q3 2026.
  • Farther Finance Advisors bought 606 Astrana Health shares in Q3 2026, an estimated $23.9K.
  • Astrana Health made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #3989 holding.
  • Farther Finance Advisors first reported a position in Astrana Health in Q4 2023 and has held it in 12 quarters since.
  • 11 funds tracked by Wall St. Rank held Astrana Health as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.